Taiwan Semiconductor Manufacturing (TSM) — closed signal from June 1, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on August 30, 2026 — -3.7% at the close.
Predicted vs. what happened
What happened
Reached its target in 21 days.
The thesis — published June 1, 2026
TSM looks like a solid short-term AI-infrastructure name because many customers need its advanced chip-making capacity, profits have been steady, and the balance sheet is strong. Nvidia-related customer news and a smaller premium for ADRs make it easier for global buyers. The stock is already somewhat extended, so measured sizing is important.
Primary drivers
- Strong demand for advanced chipmaking from AI and high-performance computing customers
- Nvidia product news adds clarity to upcoming customer orders
- Steady earnings increase confidence in future forecasts
- Smaller ADR premium can ease buying by global investors
How it played out
TSM: target reached in 21 days
Lyra published a short-term thesis at 433.43, expecting 9% growth toward 471.57. The thesis pointed to demand for advanced chipmaking from artificial intelligence and high-performance computing customers, Nvidia product news, steady earnings, and a smaller ADR premium for global buyers.
The price reached 479 on June 30, a 10.5% peak gain, and crossed the target in 21 days. It then fell and ended the window at 417.52. The published price objective was achieved inside the measurement window, so the thesis played out on its stated short-term terms.
What happened during the window
On July 16, TSMC reported second-quarter revenue of NT$1,270.38 billion and diluted earnings per share of NT$27.25. On August 10, it reported July revenue of NT$467.58 billion, up 44.7% from July 2025.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.